REHOVOT, Israel, July 31, 2025 /PRNewswire/ — Sequentify is pleased to announce the appointment of...
July 2025
SORRY, WE COULDN’T FIND THAT PAGE The page you are searching for does not exist....
AbbVie is ending development of an IL-1 asset as a monotherapy in ulcerative colitis (UC)...
TACOMA, Wash., July 31, 2025 /PRNewswire/ — Revalesio, a clinical-stage biopharmaceutical company developing treatments for acute...
Reports Second-Quarter Diluted EPS of $0.52 on a GAAP Basis, a Decrease of 32.5 Percent;...
Study results support advancing SGX945 in this difficult to treat orphan disease PRINCETON, N.J., July...
Fanapt® Q2 2025 net product sales increased by 27% to $29.3 million compared to Q2...
Researchers at the University of Colorado (CU) Anschutz Medical Campus, Montefiore Einstein Comprehensive Cancer Center...
ROCKVILLE, Md., July 31, 2025 /PRNewswire/ — REGENXBIO Inc. (Nasdaq: RGNX) today announced that it...
CytoSorb Device CytoSorbents Corporation (NASDAQ: CTSO) is a leader in the treatment of life-threatening conditions...